Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 14, 2012
After suffering from severe headaches, Kevin was told he had a brain tumor. Despite surgery, his stage 4 glioblastoma returned. But a clinical trial drug enabled Kevin to remain stable for nearly 7 years (from 2007 until his death on January 12, 2014). Find out more about his story, and how we care for patients with brain tumors at Dana-Farber/Brigham and Women's Cancer Center: http://www.dana-farber.org/Adult-Care...
Text: It started with a headache.
Kevin: Migraine headaches, you know? My head was hurting so bad, I called up my buddy who is in acupuncture and asked if maybe he could stick some needles in my head to take the pressure off. But he said it’s not a good thing, so I went and had X-rays. Next morning they operated.
Text: Kevin was told he had a brain tumor.
Kevin: No, I was scared. Brain tumor? Cancer? I never thought it would happen.
Text: Kevin’s doctor suggested a clinical trial at Dana-Farber.
Kevin: Then they said, “Well, we’re going to try to do a trial drug on you.” The drug keeps it from growing. It doesn’t make it disappear, but it just keeps it from growing, because it’s a stage 4 progressive tumor. I’m still here.
This place is great. Everyone is good. [Deb’s 00:52] been here since I started. They were a team, all of them—great. It’s like a job. I go home, I take my calendar and put a next mark on the days I’ve got to be there, you know?
Text: Kevin has remained stable for 5 years on his clinical trial drug.
Kevin: I call it ‘getting recharged,’ you know? People ask me all the time, “Hey, how’s it going?” “Oh, all right. I’m going in today to get recharged!” It’s what it seems like, and then like in two weeks, you're running out of gas. You come back in and they recharge you a little bit.
Text: Find out about clinical trials at Dana-Farber: www.Dana-Farber.org/clinicaltrials